NCT00063076 - Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia Areata | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

October 31, 2006

Study Completion Date

May 31, 2007

Conditions

Alopecia Areata

Interventions

DRUG

Targretin Gel 1%

Alopecia lesions on one-half of the head including facial hair treated, and other half on head serves as control (untreated). Starting dose once every day till Week 3 then escalate to twice a day.

Trial Locations (1)

77030

UT MD Anderson Cancer Center, Houston